Chiayi Chen
4PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 15, 2023
Evaluating the efficacy and safety of transitioning patients with multiple sclerosis from natalizumab to ocrelizumab (OCTAVE).Kyle Smoot, Horia Marginean, Tiffany Gervasi-Follmar
|Dec 24, 2021
The results of a 24-month controlled, prospective study of relapsing multiple sclerosis patients at risk for progressive multifocal encephalopathy, who switched from prolonged use of natalizumab to teriflunomide.Stanley Cohan, Tiffany Gervasi-Follmar, Aneesh Kamath
|Jul 26, 2021
Clinical outcomes of patients with multiple sclerosis treated with ocrelizumab in a US community MS center: an observational study.Kyle Smoot, Chiayi Chen, Tamela Stuchiner
|Feb 08, 2019
Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of teriflunomide therapy.Stanley L Cohan, Keith Edwards, Lindsay Lucas
Pageof 1
